Jubilant Life Sciences Ltd. - Research Center
530019 JUBILANT Group (A) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | Mar ' 16 | |
|---|---|---|---|---|---|
| Sales | 3,139.90 | 3,438.61 | 3,306.33 | 2,491.21 | 2,656.15 |
| Operating profit | 370.91 | 320.87 | 539.25 | 318.00 | 312.29 |
| Interest | 136.20 | 128.96 | 135.17 | 174.25 | 200.66 |
| Gross profit | 407.94 | 269.91 | 450.29 | 195.65 | 173.37 |
| EPS (Rs) | 20.16 | 9.27 | 16.54 | 4.97 | 4.58 |
Annual
results in details
| Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | Mar ' 16 | |
|---|---|---|---|---|---|
| Other income | 173.23 | 78.00 | 46.21 | 51.90 | 61.74 |
| Stock adjustment | -108.32 | 46.74 | -18.10 | -57.01 | -11.39 |
| Raw material | 1,683.29 | 1,874.60 | 1,644.45 | 1,244.34 | 1,348.32 |
| Power and fuel | 369.20 | 358.28 | 339.80 | - | 298.40 |
| Employee expenses | 264.90 | 265.71 | 264.42 | 226.31 | 216.18 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 559.92 | 572.41 | 536.51 | 759.57 | 492.35 |
| Provisions made | - | - | - | - | - |
| Depreciation | 107.40 | 86.48 | 82.60 | 81.13 | 86.98 |
| Taxation | -22.30 | 35.80 | 104.25 | 35.33 | 13.39 |
| Net profit / loss | 321.14 | 147.63 | 263.44 | 79.19 | 73.00 |
| Extra ordinary item | -1.70 | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 15.93 | 15.93 | 15.93 | 15.93 | 15.93 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 11.81 | 9.33 | 16.31 | 12.76 | 11.76 |
| GPM (%) | 12.31 | 7.68 | 13.43 | 7.69 | 6.38 |
| NPM (%) | 9.69 | 4.20 | 7.86 | 3.11 | 2.69 |
Mutual Fund Selector
Find the fund that is right for you
© 2021 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis